236 related articles for article (PubMed ID: 9014861)
1. The presence of cytokines in Langerhans' cell histiocytosis.
de Graaf JH; Tamminga RY; Dam-Meiring A; Kamps WA; Timens W
J Pathol; 1996 Dec; 180(4):400-6. PubMed ID: 9014861
[TBL] [Abstract][Full Text] [Related]
2. Monokine expression in Langerhans' cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
Foss HD; Herbst H; Araujo I; Hummel M; Berg E; Schmitt-Gräff A; Stein H
J Pathol; 1996 May; 179(1):60-5. PubMed ID: 8691347
[TBL] [Abstract][Full Text] [Related]
3. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis.
Kannourakis G; Abbas A
Br J Cancer Suppl; 1994 Sep; 23():S37-40. PubMed ID: 8075004
[TBL] [Abstract][Full Text] [Related]
4. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells.
de Graaf JH; Tamminga RY; Kamps WA; Timens W
Am J Pathol; 1995 Oct; 147(4):1161-71. PubMed ID: 7573361
[TBL] [Abstract][Full Text] [Related]
5. Langerhans' cell histiocytosis cells are activated Langerhans' cells.
Emile JF; Fraitag S; Leborgne M; de Prost Y; Brousse N
J Pathol; 1994 Oct; 174(2):71-6. PubMed ID: 7965409
[TBL] [Abstract][Full Text] [Related]
6. Langerhans' cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation.
de Graaf JH; Tamminga RY; Kamps WA; Timens W
Am J Pathol; 1994 Mar; 144(3):466-72. PubMed ID: 7510455
[TBL] [Abstract][Full Text] [Related]
7. Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?
Garabedian L; Struyf S; Opdenakker G; Sozzani S; Van Damme J; Laureys G
Eur Cytokine Netw; 2011 Sep; 22(3):148-53. PubMed ID: 22001902
[TBL] [Abstract][Full Text] [Related]
8. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment.
Tazi A; Moreau J; Bergeron A; Dominique S; Hance AJ; Soler P
J Immunol; 1999 Sep; 163(6):3511-5. PubMed ID: 10477625
[TBL] [Abstract][Full Text] [Related]
9. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.
Egeler RM; Favara BE; van Meurs M; Laman JD; Claassen E
Blood; 1999 Dec; 94(12):4195-201. PubMed ID: 10590064
[TBL] [Abstract][Full Text] [Related]
10. Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease.
da Costa CE; Egeler RM; Hoogeboom M; Szuhai K; Forsyth RG; Niesters M; de Krijger RR; Tazi A; Hogendoorn PC; Annels NE
J Pathol; 2007 Jun; 212(2):188-97. PubMed ID: 17447723
[TBL] [Abstract][Full Text] [Related]
11. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis.
Annels NE; Da Costa CE; Prins FA; Willemze A; Hogendoorn PC; Egeler RM
J Exp Med; 2003 May; 197(10):1385-90. PubMed ID: 12743170
[TBL] [Abstract][Full Text] [Related]
12. Normal monocyte-derived dendritic cell function in patients with Langerhans-cell-histiocytosis.
Holter W; Ressmann G; Grois N; Lehner M; Parolini O; Gadner H
Med Pediatr Oncol; 2002 Sep; 39(3):181-6. PubMed ID: 12210447
[TBL] [Abstract][Full Text] [Related]
13. [Cytokines in children with immunodeficiencies].
Kowalczyk D
Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
[TBL] [Abstract][Full Text] [Related]
14. Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage.
Egeler RM; van Halteren AG; Hogendoorn PC; Laman JD; Leenen PJ
Immunol Rev; 2010 Mar; 234(1):213-32. PubMed ID: 20193021
[TBL] [Abstract][Full Text] [Related]
15. Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.
Quispel WT; Stegehuis-Kamp JA; Santos SJ; Egeler RM; van Halteren AG
J Interferon Cytokine Res; 2015 Oct; 35(10):831-9. PubMed ID: 26381039
[TBL] [Abstract][Full Text] [Related]
16. Biology of Langerhans cells and Langerhans cell histiocytosis.
Bechan GI; Egeler RM; Arceci RJ
Int Rev Cytol; 2006; 254():1-43. PubMed ID: 17147996
[TBL] [Abstract][Full Text] [Related]
17. Macrophages in Langerhans cell histiocytosis are differentiated toward M2 phenotype: their possible involvement in pathological processes.
Ohnishi K; Komohara Y; Sakashita N; Iyama K; Murayama T; Takeya M
Pathol Int; 2010 Jan; 60(1):27-34. PubMed ID: 20055949
[TBL] [Abstract][Full Text] [Related]
18. Prominent Langerhans' cell migration in the arthropod bite reactions simulating Langerhans' cell histiocytosis.
Kim SH; Kim DH; Lee KG
J Cutan Pathol; 2007 Dec; 34(12):899-902. PubMed ID: 18001411
[TBL] [Abstract][Full Text] [Related]
19. Expression of GM-CSF receptor by Langerhans' cell histiocytosis cells.
Emile JF; Fraitag S; Andry P; Leborgne M; Lellouch-Tubiana A; Brousse N
Virchows Arch; 1995; 427(2):125-9. PubMed ID: 7582241
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter.
McClain KL; Laud P; Wu WS; Pollack MS
Med Pediatr Oncol; 2003 Dec; 41(6):502-7. PubMed ID: 14595706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]